UY24997A1 - Nuevos derivados de triazole, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen - Google Patents

Nuevos derivados de triazole, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen

Info

Publication number
UY24997A1
UY24997A1 UY24997A UY24997A UY24997A1 UY 24997 A1 UY24997 A1 UY 24997A1 UY 24997 A UY24997 A UY 24997A UY 24997 A UY24997 A UY 24997A UY 24997 A1 UY24997 A1 UY 24997A1
Authority
UY
Uruguay
Prior art keywords
group
alkyl
defined above
pharmaceutical compositions
preparation
Prior art date
Application number
UY24997A
Other languages
English (en)
Inventor
Gully Danielle
Frehel Daniel
Despeyroux Pierre
De Cointet Paul
Bras Jean Pierre
Bignon Eric
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of UY24997A1 publication Critical patent/UY24997A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

La presente invención se refiere a derivados de triazole de fórmula (I), en la que: R1 representa alquilo, un grupo -(CH2)n-G donde n varía de 0 a 5 y G representa un grupo hidrocarbonado mono- o policíclico no aromático, un grupo -(CH2)nNR2R3 en el cual n representa un número entero de 1 a 6 y R2 y R3 idénticos o diferentes representan un alquilo o constituyen con el átomo de N al cual están unidos un grupo morfolino, piperidino, pirrolidinilo o piperazinilo; X1, X2, X3 o X4 representan cada uno independientemente, un átomo de H, de halógeno, un alquilo, un alcoxi o un trifluorometilo; R4 representa H, alquilo, un grupo -(CH2)nCOOR5 en el cual n es tal como se definió anteriormente y R5 representa H, alquilo o aril-alquilo, un grupo -(CH2)nOR5 o un grupo -(CH2)nNR2R3 en los cuales n, R2, R3 y R5 son tal como se los ha definido precedentemente, un grupo -(CH2)n-tetrazolilo en el cual n es como se definió anteriormente, o R4 representa uno de esos grupos en forma de sal de un metal alcalino o alcalinotérreo; Y1, Y2 e Y3 representan independientemente, H, halógeno, alquilo, alcoxi, nitro, ciano, acilamino, carbamoilo, trifluorometilo, un grupo COOR6 en el cual R6 representa H o alquilo; o una de sus sales o solvatos. Asimismo, se reivindica un procedimiento para su preparación, y composiciones farmacéuticas que los contienen. Dichos compuestos son agonistas de los receptores CCK-A (colecistoquinina-A), y por tanto son útiles en el tratamiento de desórdenes alimenticios, disquinesis tardía y trastornos gastrointestinales. Ej. no limitante: 2-[N-[5-(4-cloro-2,5-dimetoxifenil)-1-(2-ciclohexiletil)-1H-1,2,4-triazol-3-il]carbamoilo]-4,5-dimetil-1-[3-(2H-1,2,3,4-tetrazol-5-il)propil]-1H-indol
UY24997A 1997-05-13 1998-05-12 Nuevos derivados de triazole, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen UY24997A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9705850A FR2763337B1 (fr) 1997-05-13 1997-05-13 Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
UY24997A1 true UY24997A1 (es) 2000-10-31

Family

ID=9506830

Family Applications (1)

Application Number Title Priority Date Filing Date
UY24997A UY24997A1 (es) 1997-05-13 1998-05-12 Nuevos derivados de triazole, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen

Country Status (35)

Country Link
EP (1) EP0984960B1 (es)
JP (1) JP2001524980A (es)
KR (1) KR20010012541A (es)
CN (1) CN1263528A (es)
AR (1) AR011729A1 (es)
AT (1) ATE232207T1 (es)
AU (1) AU725530B2 (es)
BR (1) BR9811465A (es)
CA (1) CA2289573A1 (es)
CO (1) CO4940485A1 (es)
CZ (1) CZ289484B6 (es)
DE (1) DE69811223T2 (es)
DK (1) DK0984960T3 (es)
DZ (1) DZ2486A1 (es)
EE (1) EE9900524A (es)
ES (1) ES2190081T3 (es)
FR (1) FR2763337B1 (es)
GT (1) GT199800068A (es)
HR (1) HRP980258B1 (es)
HU (1) HUP0002763A3 (es)
ID (1) ID22911A (es)
IL (1) IL132903A0 (es)
IS (1) IS5235A (es)
NO (1) NO995513L (es)
NZ (1) NZ500637A (es)
PL (1) PL336772A1 (es)
RU (1) RU2175323C2 (es)
SI (1) SI0984960T1 (es)
SK (1) SK154299A3 (es)
TR (1) TR199902795T2 (es)
TW (1) TW396155B (es)
UY (1) UY24997A1 (es)
WO (1) WO1998051686A1 (es)
YU (1) YU57999A (es)
ZA (1) ZA983997B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802530B1 (fr) * 1999-12-17 2002-02-22 Sanofi Synthelabo Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2815963B1 (fr) * 2000-10-26 2003-02-28 Sanofi Synthelabo Nouveaux derives du triazole et les compositions pharmaceutiques les contenant
AU2002226330A1 (en) * 2000-10-26 2002-05-06 Sanofi-Synthelabo Triazole derivatives and pharmaceutical compositions comprising them
HUP0004741A2 (hu) * 2000-11-28 2002-12-28 Sanofi-Synthelabo Kémiai eljárás tiazolszármazékok előállítására és új intermedier
US20050014805A1 (en) * 2001-10-12 2005-01-20 Chenzhi Zhang Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
EP1314733A1 (en) * 2001-11-22 2003-05-28 Aventis Pharma Deutschland GmbH Indole-2-carboxamides as factor Xa inhibitors
EP1479677A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH New indole derivatives as factor xa inhibitors
EP1532980A1 (en) * 2003-11-24 2005-05-25 Novo Nordisk A/S N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
GB0403038D0 (en) * 2004-02-11 2004-03-17 Novartis Ag Organic compounds
ATE528006T1 (de) * 2007-01-26 2011-10-15 Merck Sharp & Dohme Substituierte aminopyrimidine als cholecystokinin-1-rezeptormodulatoren
WO2010007046A2 (en) * 2008-07-15 2010-01-21 Novartis Ag Organic compounds
US8580831B2 (en) * 2009-06-09 2013-11-12 Actelion Pharmaceuticals Ltd. Fluorinated aminotriazole derivatives
EP2490659B1 (de) * 2009-10-22 2017-03-01 Henkel AG & Co. KGaA Mittel zur temporären verformung keratinhaltiger fasern, enthaltend eine nichtionische, mittels propylenoxid modifizierte stärke und ein chitosan
CN106928147A (zh) * 2017-03-14 2017-07-07 华东师范大学 三环二萜类似物及其制备方法、及其在制备抗前列腺癌药物中的应用
CN107271623A (zh) * 2017-07-27 2017-10-20 青岛啤酒股份有限公司 基于人体饱腹感的啤酒可饮性评价方法
MX2022004142A (es) 2019-10-07 2022-09-21 Kallyope Inc Agonistas de gpr119.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701708B1 (fr) * 1993-02-19 1995-05-19 Sanofi Elf Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament.
FR2703995B1 (fr) * 1993-04-16 1995-07-21 Sanofi Elf 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
IL132903A0 (en) 2001-03-19
AR011729A1 (es) 2000-08-30
TW396155B (en) 2000-07-01
ID22911A (id) 1999-12-16
FR2763337A1 (fr) 1998-11-20
CN1263528A (zh) 2000-08-16
NO995513D0 (no) 1999-11-11
SI0984960T1 (en) 2003-06-30
FR2763337B1 (fr) 1999-08-20
EP0984960B1 (fr) 2003-02-05
YU57999A (sh) 2002-06-19
DZ2486A1 (fr) 2003-02-01
IS5235A (is) 1999-10-29
DK0984960T3 (da) 2003-05-26
EP0984960A1 (fr) 2000-03-15
AU7659998A (en) 1998-12-08
CA2289573A1 (fr) 1998-11-19
NO995513L (no) 2000-01-12
NZ500637A (en) 2000-11-24
DE69811223T2 (de) 2003-11-27
BR9811465A (pt) 2000-09-12
HUP0002763A3 (en) 2002-05-28
HRP980258B1 (en) 2002-08-31
RU2175323C2 (ru) 2001-10-27
PL336772A1 (en) 2000-07-17
KR20010012541A (ko) 2001-02-15
AU725530B2 (en) 2000-10-12
GT199800068A (es) 1999-11-11
EE9900524A (et) 2000-06-15
ZA983997B (en) 1999-11-12
HRP980258A2 (en) 1999-02-28
CO4940485A1 (es) 2000-07-24
JP2001524980A (ja) 2001-12-04
ATE232207T1 (de) 2003-02-15
WO1998051686A1 (fr) 1998-11-19
SK154299A3 (en) 2000-05-16
CZ289484B6 (cs) 2002-01-16
CZ400699A3 (cs) 2000-02-16
DE69811223D1 (de) 2003-03-13
ES2190081T3 (es) 2003-07-16
TR199902795T2 (xx) 2000-02-21
HUP0002763A2 (hu) 2001-06-28

Similar Documents

Publication Publication Date Title
UY24997A1 (es) Nuevos derivados de triazole, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
RU2439068C2 (ru) Модуляторы mglur5
WO2003024967A3 (en) Indolizines as kinase protein inhibitors
AR048642A1 (es) Compuestos de metil-aril o heteroaril-amida sustituida utiles como antagonistas del receptor de prostaglandinas e2; composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento
DK0794949T3 (da) Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler
AR044163A1 (es) Derivados de pirazol sustituidos, composiciones farmaceuticas que los contienen y compuestos relacionados como antagonistas del receptor de bradiquinina b1
ATE334973T1 (de) Chinazolinverbindungen
FI960399A0 (fi) Perhydroisoindolijohdannaisia P-aineen antagonisteina
AR039127A1 (es) Compuesto de quinolina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y uso del mismo para la fabricacion de un medicamento
AR035759A1 (es) Compuestos acilurea antagonistas de la funcion mpc-1, un procedimiento para su preparacion, composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
ATE109481T1 (de) Diazinderivate als angiotensin ii rezeptor antagonisten.
UY29312A1 (es) Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones
EA200701779A1 (ru) Производные (1,5-дифенил-1н-пиразол-3-ил)оксадиазола, их получение и их применение в терапии
DE59408213D1 (de) Pyrrolidin- und oxazolidin derivate , ihre herstellung und ihre verwendung als thrombocyten-aggregations-hemmer
AR050208A1 (es) Compuesto de heteroaril sulfonamida sustituida, procedimiento para la preparacion del mismo, composicion farmaceutica que lo comprende y su uso para preparar un medicamento
AR006906A1 (es) Derivados de indazol sustituidos, composiciones farmaceuticas que los contienen, uso de los mismos e intermediarios de sintesis
CO5200757A1 (es) Derivados de 4-indol benzamidas con actividad contra la osteoporosis, sus sales farmaceuticamente aceptables y composiciones farmaceuticas que los contienen
AR035456A1 (es) Compuestos derivados de dihidro-benzo[b][1,4]-diazepin-2-ona , su empleo, un procedimiento para prepararlos y medicamentos que los contienen
RU2004117170A (ru) Комбинация ингибитора циклооксигеназы-2 и инибитора гистондезацетилазы
FI962952A0 (fi) Delta 12,13-iso-taksolianalogit, niiden antineoplastinen käyttö ja niitä sisältävät farmaseuttiset koostumukset
PE20011115A1 (es) Etanos tri-aril-sustituidos inhibidores de pde4
UY25987A1 (es) Procedimiento para preparar complejo del inhibidor de ras-fa rnesiltransferasa y sulfobutileter-7-beta-ciclodextrina o 2- hidroxipropil-beta-ciclodextrina y método
IL114241A0 (en) Thiazolidine derivatives their preparation and compositions containing them
ATE416157T1 (de) Inhibitoren von integrin alpha-v-beta-6
TR200000725T2 (tr) Bir monoamin oksidaz inhibitörü ve h5-HT1B antagonistinin bileşimi

Legal Events

Date Code Title Description
VENC Patent expired

Effective date: 20180512